financetom
Business
financetom
/
Business
/
JetBlue posts surprise profit, delays buying $3 billion worth of Airbus planes
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JetBlue posts surprise profit, delays buying $3 billion worth of Airbus planes
Jul 30, 2024 4:40 AM

(Reuters) - JetBlue Airways ( JBLU ) posted a surprise second-quarter profit and delayed plans to buy Airbus planes worth about $3 billion, aiming for profitability through cost-cuts, sending its shares up 6% before the bell on Tuesday.

The airline had earlier this year decided to cut some of its loss-making routes and markets, and moved resources to better-performing regions.

The New York-based carrier has been grappling with higher operating costs as inspections of Pratt & Whitney's Geared Turbofan engines have led to the grounding of several aircraft.

JetBlue ( JBLU ) said on Tuesday it was targeting $800 million to $900 million in core profits in 2027.

"We are actively reinvesting in our core geographies in New York, New England, Florida and Puerto Rico, while exiting routes and BlueCities that don't meet our financial hurdle rate," President Marty St. George said.

Airlines are experiencing a summer travel boom, with expectations to transport 271 million passengers during the season, a 6.3% rise from last year, according to Airlines for America, a group that represents major U.S. carriers.

JetBlue ( JBLU ) reported an adjusted profit of 8 cents per share for second quarter ended June 30, compared with analysts' average estimates of a 11 cents loss, according to LSEG data.

For the third quarter, it expects revenue to fall in the range of 1.5% to 5.5%, while analysts were expecting it to grow nearly 1%.

The company's total operating revenue fell 6.9% to $2.43 billion, compared with Wall Street expectations of $2.40 billion.

(Reporting by Shivansh Tiwary in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quanta beats fourth-quarter profit estimates on strong infrastructure demand
Quanta beats fourth-quarter profit estimates on strong infrastructure demand
Feb 20, 2025
(Reuters) - Energy contractor Quanta Services ( PWR ) beat fourth-quarter profit estimates on Thursday, on higher demand for its services related to power and infrastructure, sending shares up 7% before the bell. Warming global temperatures have aggravated extreme weather conditions, raising the severity of hurricanes and floods in the U.S. and increasing the need for power grid restoration and...
Baxter International's Q4 Adjusted Earnings Fall, Revenue Rises; Q1, 2025 Guidance Issued
Baxter International's Q4 Adjusted Earnings Fall, Revenue Rises; Q1, 2025 Guidance Issued
Feb 20, 2025
07:43 AM EST, 02/20/2025 (MT Newswires) -- Baxter International ( BAX ) reported Q4 adjusted earnings from continuing operations Thursday of $0.58 per diluted share, down from $0.65 a year earlier. Analysts polled by FactSet expected $0.52. Revenue for the quarter ended Dec. 31 was $2.75 billion, compared with $2.73 billion a year earlier. Analysts surveyed by FactSet expected $2.67...
Southern Company's Q4 Non-GAAP Earnings Fall, Total Operating Revenue Increases
Southern Company's Q4 Non-GAAP Earnings Fall, Total Operating Revenue Increases
Feb 20, 2025
07:41 AM EST, 02/20/2025 (MT Newswires) -- Southern Company ( SO ) reported Q4 non-GAAP earnings Thursday of $0.50 per share, down from $0.64 a year earlier. Analysts polled by FactSet expected $0.51. Total operating revenue for the quarter ended Dec. 31 was $6.34 billion, up from $6.05 billion a year earlier. Analysts surveyed by FactSet expected $5.9 billion. ...
Telix Pharmaceuticals 2024 Revenue Increases; Issues 2025 Revenue Outlook
Telix Pharmaceuticals 2024 Revenue Increases; Issues 2025 Revenue Outlook
Feb 20, 2025
07:45 AM EST, 02/20/2025 (MT Newswires) -- Telix Pharmaceuticals ( TLX ) reported 2024 revenue Thursday of 783.2 million Australian dollars ($499.0 million), up from AU$502.5 million a year earlier. Analysts polled by FactSet expected AU$774.8 million. The biopharmaceutical firm said it expects 2025 revenue of AU$1.18 billion to AU$1.23 billion. Analysts surveyed by FactSet expect AU$1.09 billion. Shares of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved